期刊文献+

基于质谱技术研究黑色素瘤血清特异性O-糖链

Mass spectrometry analysis of melanoma related O-glycans in serum
原文传递
导出
摘要 对接种和未接种B16黑色素瘤细胞的C57小鼠进行血清O-糖链比较糖组学研究,寻找黑色素瘤血清特异性O-糖链.小鼠血清10μL,β-消除反应释放O-糖链.反应混合物经石墨化炭黑固相萃取小柱(GCC SPE)分离纯化后,用于MALDI-Qit-TOF-MS分析.通过Launchpad软件采集并输出质谱数据,MATLAB进行数据解析,找到了10个稳定出现的差异糖链质谱峰.利用串联质谱分析了其中5个主要差异糖链的结构. Glycomics comparison was carried out for screening melanoma serum biomarkers between C57 mouse with and without B16 implanted.O-glycans were released from 10 μL serum by β-elimination,purified by GCC SPE and analyzed by MALDI-QIT-TOF-MS.MS raw data was acquired and exported by Launchpad software.MATLAB was then applied for further data analysis.10 glycans were considered to be firmly changed after B16 implantation and 5 of them were picked for MS/MS for structure analysis.
出处 《中国科学:化学》 CAS CSCD 北大核心 2010年第5期517-522,共6页 SCIENTIA SINICA Chimica
基金 上海市教育委员会科研创新项目(10YZ212) 国家自然科学基金项目(30900254)资助
关键词 质谱 糖组学 黑色素瘤 分子标志物 mass spectrometry glycomics melanoma biomarkers
  • 相关文献

参考文献19

  • 1Dancey AL, Mahon BS, Rayatt SS. A review of diagnostic imaging in melanoma. J Plastic Reconstructive and Aesthetic Surgery, 2008, 61(11): 1275 1283.
  • 2Psaty EL, Halpern AC. Current and emerging technologies in melanoma diagnosis: the state of the art. Clinics in Dermatology, 2009, 27(1): 35--45.
  • 3Taniguchi N. Toward cancer biomarker discovery using the glycomics approach. Proteomics, 2008, 8(16): 3205--3208.
  • 4Fuster MM, Esko JD. The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer, 2005, 5(7): 526--542.
  • 5Kirmiz C, Li B, An HJ, Clowers BH, Chew HK, Lam KS, Ferrige A, Alecio R, Borowsky AD, Sulaimon S, Lebrilla CB, Miyamoto S. A serum glycomics approach to breast cancer biomarkers. Mol Cell Proteomics, 2007, 6(1): 43--55.
  • 6Hollingsworth MA, Swanson BJ. Mucins in cancer: protection and control of the cell surface. Nat Rev, 2004, 4(1): 45--60.
  • 7Blomme B, Van Steenkiste C, Callewaert N, Van Vlierberghe H. Alteration of protein glycosylation in liver diseases. J Hepatology, 2009, 50(3): 592 603.
  • 8Bosques C J, Raguram S, Sasisekharan R. The sweet side of biomarker discovery. Nat Biotechnol, 2006, 24(9): 1100--1101.
  • 9An HJ, Miyamoto S, Lancaster KS, Kirmiz C, Li BS, Lain KS, Leiserowitz GS, Lebrilla CB. Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer. J Proteome Res, 2006, 5(7): 1626--1635.
  • 10Li B, An HJ, Kirmiz C, Lebrilla CB, Lam KS, Miyamoto S. Glycoproteomic analyses of ovarian cancer cell lines and sera from ovarian cancer patients show distinct glycosylation changes in individual proteins. J Proteome Res, 2008, 7(9): 3776--3788.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部